首页> 美国卫生研究院文献>other >Should Sputum Smear Examination Be Carried Out at the End of the Intensive Phase and End of Treatment in Sputum Smear Negative Pulmonary TB Patients?
【2h】

Should Sputum Smear Examination Be Carried Out at the End of the Intensive Phase and End of Treatment in Sputum Smear Negative Pulmonary TB Patients?

机译:是否应痰涂片检查是在痰涂片阴性肺结核病人强化期和治疗结束的进行到底?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe Indian guidelines on following up sputum smear-negative Pulmonary tuberculosis (PTB) patients differ from the current World Health Organization (WHO) guidelines in that the former recommends two follow up sputum examinations (once at the end of intensive phase and the other at the end of treatment) while the latter recommends only one follow up sputum smear microscopy examination, which is done at the end of the intensive phase. This study was conducted to examine if there was any added value in performing an additional sputum smear examination at the end of treatment within the context of a national TB program.
机译:背景印度关于随访痰涂片阴性肺结核(PTB)患者的指南与当前的世界卫生组织(WHO)指南的不同之处在于,前者建议进行两次随访痰检查(一次在强化阶段结束时进行,另一次在痰液阶段结束时进行)。治疗结束),而后者建议仅进行一次随访痰涂片显微镜检查,该检查在强化阶段结束时进行。进行这项研究的目的是在国家结核病规划的背景下,在治疗结束时进行额外的痰涂片检查,以检查是否有任何附加价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号